The approach to human being--the important factor in the treatment of disease and patient
Hadzić, N.
Acta Medica Croatica Casopis Hravatske Akademije Medicinskih Znanosti 67(3): 207-209
2013
ISSN/ISBN: 1330-0164 PMID: 25007429 Document Number: 667633
Document emailed within 1 workday
Related Documents
Egydio, P.H. 2008: Surgical treatment of Peyronie's disease: choosing the best approach to improve patient satisfaction Asian Journal of Andrology 10(1): 158-166Kehrl, J.H.; Roberts, A.B.; Wakefield, L.M.; Jakowlew, S.; Sporn, M.B.; Fauci, A.S. 1986: Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes Journal of Immunology 137(12): 3855-3860
Van Lieshout, A.W.T.; Creemers, M.C.W.; Radstake, T.R.D.J.; Elving, L.D.; van Riel, P.L.C.M. 2008: Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha Journal of Rheumatology 35(5): 938-939
Hellström, O. 2011: Beyond the physician's knowledge map. Important to see the patient as a human being--not the other way round Lakartidningen 108(37): 1773-1774
Reeve, J.G.; Schwander, J.; Bleehen, N.M. 1993: IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours? Growth Regulation 3(1): 82-84
Richard, C.; Sedano, C.; Cuadrado, M.A.; Iriondo, A.; Bello, C.; Gandarillas, M.A.; Zubizarreta, A. 1986: Effect of a thymic factor on the concentration of a factor VIIi inhibitor in a patient with treated Hodgkin's disease Thrombosis and Haemostasis 55(2): 299-300
Rogers, B.C. 1996: Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease Neurotoxicology 17(3-4): 865-870
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J. 1995: Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts Transplantation Proceedings 27(1): 326-327
Roos, R.A.; Wintzen, A.R.; Will, R.G.; Ironside, J.W.; van Duinen, S.G. 1996: A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone Nederlands Tijdschrift Voor Geneeskunde 140(22): 1190-1193
Zollner, U.; Neumann, C.; Zollner, K.-P. 2013: Probability of success of conservative treatment of infertility: exact timing as an important prognostic factor Journal of Reproductive Medicine 58(5-6): 205-211
Chiang, K-Yueh.; Abhyankar, S.; Bridges, K.; Godder, K.; Henslee-Downey, J.P. 2002: Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease Transplantation 73(4): 665-667
Kozlov, I.I. 1976: Sanatorium-health resort treatment is an important factor in strengthening the health of the population Zdravookhranenie Rossiiskoi Federatsii 7: 3-7
Carr, A.J. 1996: Margaret Holroyd Prize Essay. A patient-centred approach to evaluation and treatment in rheumatoid arthritis: the development of a clinical tool to measure patient-perceived handicap British Journal of Rheumatology 35(10): 921-932
Handa, R. 1999: Approach to a patient with connective tissue disease National Medical Journal of India 12(5): 228-229
Tubach, F.; Wells, G.A.; Ravaud, P.; Dougados, M. 2005: Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues Journal of Rheumatology 32(10): 2025-2029
Lassere, M.N.; van der Heijde, D.; Johnson, K.R.; Boers, M.; Edmonds, J. 2001: Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials Journal of Rheumatology 28(4): 892-903
Bialas, T.; Kolitz, J.; Levi, E.; Polivka, A.; Oez, S.; Miller, G.; Welte, K. 1988: Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin Cancer Research 48(4): 891-898
Grujic, B.; Jovanovic, D.; Djordjevic, I. 2011: One-stage transanal surgical technique for Hirschsprung's disease: is the age of a patient a limiting factor? Acta Chirurgica Belgica 111(5): 338-341
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Martin, I.F. 1973: An approach to physiotherapy in the treatment of the grossly obese patient PhysioTherapy 59(7): 213-215